Goldman-Sachs-Group

Filing Details

13F-HR/A • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-16
Total Holdings
11,314
Total Value
470725650026
Accession Number
0000769993-25-000301
Form Type
13F-HR/A
Manager Name
Goldman-Sachs-Group
Data Enrichment
86% identified
9,763 identified1,551 unidentified

Holdings

11,314 positions • $470.7B total value
Manager:
Search and click to pin securities to the top
Page 252 of 253
G63369113
Shares:22.9K
Value:$5.3K
% of Portfolio:0.0% ($5.3K/$470.7B)
Brand Engagement Network Inc.
Shares:273.9K
Value:$5.2K
% of Portfolio:0.0% ($5.2K/$470.7B)
M6000J127
Shares:461.5K
Value:$5.1K
% of Portfolio:0.0% ($5.1K/$470.7B)
Abpro Holdings, Inc.
Shares:179.1K
Value:$4.6K
% of Portfolio:0.0% ($4.6K/$470.7B)
G8675V127
Shares:17.9K
Value:$4.5K
% of Portfolio:0.0% ($4.5K/$470.7B)
29415V117
Shares:125.0K
Value:$4.1K
% of Portfolio:0.0% ($4.1K/$470.7B)
Passage BIO, Inc.
Shares:11.6K
Value:$4.1K
% of Portfolio:0.0% ($4.1K/$470.7B)
Co-Diagnostics, Inc.
Shares:13.0K
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$470.7B)
G85727116
Shares:21.2K
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$470.7B)
Above Food Ingredients Inc.
Shares:168.6K
Value:$3.7K
% of Portfolio:0.0% ($3.7K/$470.7B)
Cellectar Biosciences, Inc.
Shares:10.8K
Value:$3.4K
% of Portfolio:0.0% ($3.4K/$470.7B)
74449F118
Shares:200.1K
Value:$3.4K
% of Portfolio:0.0% ($3.4K/$470.7B)
Ernexa Therapeutics Inc.
Shares:18.1K
Value:$3.2K
% of Portfolio:0.0% ($3.2K/$470.7B)
Adaptimmune Therapeutics PLC
Shares:16.1K
Value:$3.2K
% of Portfolio:0.0% ($3.2K/$470.7B)
37961B112
Shares:34.8K
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$470.7B)
Aeva Technologies, Inc.
Shares:35.2K
Value:$2.8K
% of Portfolio:0.0% ($2.8K/$470.7B)
Beneficient
Shares:379.7K
Value:$2.8K
% of Portfolio:0.0% ($2.8K/$470.7B)
M7S64L107
Shares:19.0K
Value:$2.6K
% of Portfolio:0.0% ($2.6K/$470.7B)
N2OFF, Inc.
Shares:10.6K
Value:$2.5K
% of Portfolio:0.0% ($2.5K/$470.7B)
VEEA INC.
Shares:32.3K
Value:$2.4K
% of Portfolio:0.0% ($2.4K/$470.7B)